Your browser doesn't support javascript.
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2.
Sapkal, Gajanan N; Yadav, Pragya D; Ella, Raches; Deshpande, Gururaj R; Sahay, Rima R; Gupta, Nivedita; Vadrevu, Krishna Mohan; Abraham, Priya; Panda, Samiran; Bhargava, Balram.
  • Sapkal GN; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
  • Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
  • Ella R; Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana 500078, India.
  • Deshpande GR; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
  • Sahay RR; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
  • Gupta N; Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box 4911, Ansari Nagar, New Delhi 110029, India.
  • Vadrevu KM; Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana 500078, India.
  • Abraham P; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
  • Panda S; Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box 4911, Ansari Nagar, New Delhi 110029, India.
  • Bhargava B; Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box 4911, Ansari Nagar, New Delhi 110029, India.
J Travel Med ; 28(4)2021 Jun 01.
Article in English | MEDLINE | ID: covidwho-1153231

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article Affiliation country: Jtm

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article Affiliation country: Jtm